References
Castano, L. & Eisenbarth, G.S. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8, 647–679 ( 1990).
Cordell, H.J. & Todd, J.A. Multifactorial inheritance in type 1 diabetes. Trends Genet. 11, 499– 504 (1995).
Yan, G., Fu Y. & Faustman, D.L. Reduced expression of Tap1 and Lmp2 antigen-processing genes in the nonobese diabetic (NOD) mouse due to a mutation in their shared bidirectional promoter. J. Immunol. 159, 3068–3080 (1997).
Hayashi, T. & Faustman, D. NOD mice are defective in proteasome production and activation of NF-κB. Mol. Cell. Biol. 19, 8646–8659 (1999).
Palombella, V.J., Rando, O.J., Goldberg, A.L. & Maniatis, T. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78, 773–785 (1994).
Bogyo, M., Shin, S., McMaster, J.S. & Ploegh, H.L. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. Chem. Biol. 5, 307– 320 (1998).
Tanaka, K., Tanahashi, N., Tsurumi, C., Yokota, K.Y. & Shimbara, N. Proteasomes and antigen processing . Adv. Immunol. 64, 1–38 (1997).
Griffin, T.A. et al. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-γ)-inducible subunits. J. Exp. Med. 187, 97–104 (1998).
Nandi, D., Iyer, M.N. & Monaco, J.J. Molecular and serological analysis of polymorphisms in the murine major histocompatibility complex-encoded proteasome subunits, LMP-2 and LMP-7. Exp. Clin. Immunogenetics 13, 20–29 (1996).
Salter, R.D., Howell, D.N. & Cresswell, P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21, 235–246 (1985).
Nandi, D., Woodward, E., Ginsburg, D.B. & Monaco, J.J. Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits. EMBO J. 16 , 5363–5375 (1997).
Van Kaer, L. et al. Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Immunity 1, 533– 541 (1994).
Makino, S. et al. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29, 1–13 (1980).
Stephens, L.A., Thomas, H.E. & Kay, T.W. Protection of NIT-1 pancreatic beta-cells from immune attack by inhibition of NF-κB. J. Autoimmun. 10, 293–298 (1997).
Sears, C., Olesen, J., Rubin, D., Finley, D. & Maniatis, T. NF-κB p105 processing via the ubiquitin-proteasome pathway. J. Biol. Chem. 273, 1409– 1419 (1998).
Gueckel, R., Enenkel, C., Wolf, D.H. & Hilt, W. Mutations in the yeast proteasome beta-type subunit Pre3 uncover position-dependent effects on proteasomal peptidase activity and in vivo function. J. Biol. Chem. 273, 19443–19452 (1998).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hayashi, T., Kodama, S. & Faustman, D. Reply to 'LMP2 expression and proteasome activity in NOD mice' . Nat Med 6, 1065–1066 (2000). https://doi.org/10.1038/80353
Issue Date:
DOI: https://doi.org/10.1038/80353
- Springer Nature America, Inc.
This article is cited by
-
A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice
British Journal of Cancer (2012)
-
TNF receptor 2 pathway: drug target for autoimmune diseases
Nature Reviews Drug Discovery (2010)